Neonatal hyperbilirubinemia: past lessons, current practices, and future directions

Area of Science:

• Neonatal Medicine
• Pediatric Neurology
• Public Health

Background:

• Neonatal hyperbilirubinemia is common, with potential for severe neurodevelopmental complications if untreated.
• Historical approaches to screening, diagnosis, and treatment have evolved significantly.
• Global health disparities persist in managing neonatal jaundice.

Purpose of the Study:

• To review the historical and current management of neonatal hyperbilirubinemia.
• To explore emerging innovations in diagnostics and therapeutics.
• To address global disparities and future directions in research and precision medicine.

Main Methods:

• Comprehensive literature search of PubMed, Scopus, and Cochrane databases.
• Focus on epidemiology, diagnostic strategies, and clinical management guidelines.
• Analysis of historical progression and current standards of care.

Main Results:

• Phototherapy remains a primary treatment, with adjunctive therapies used for high-risk infants.
• Advancements in screening and diagnostics are enabling personalized care, especially in resource-limited settings.
• Emerging innovations include artificial intelligence and new pharmacologic agents.

Conclusions:

• Early recognition and intervention are vital for preventing acute and long-term consequences of neonatal hyperbilirubinemia.
• Technological advancements and global policy efforts are necessary to achieve equity in neonatal jaundice outcomes.
• Improved diagnostics and therapeutics hold promise for reducing neonatal morbidity and mortality worldwide.